PwC notes that the next phase of the obesity drug market will likely be defined by expanded indications, improved delivery methods and therapies offering better long-term patient adherence
By understanding your genetic predispositions related to appetite regulation, satiety sensitivity, and metabolic rate, PlexusDx helps match you with the most effective GLP-1 formulationwhether that's semaglutide, tirzepatide, or the dual-compound GLP-Squared protocol
Previous studies have found increased risk of gastrointestinal adverse events with use of glucagon-like peptide 1 (GLP-1) agonists in patients with diabetes
Psychosomatics 44:3843 Papadopoulos AS, Cleare AJ (2012) Hypothalamicpituitaryadrenal axis dysfunction in chronic fatigue syndrome
Our standards are not
Theres no good evidence that GLP-1RAs cause erectile dysfunction (ED), despite what click-baity headlines might suggest